Abstract
Purpose
Combined resection of primary colorectal cancer and synchronous hepatic metastases has been shown to be safe and associated with acceptable oncologic outcomes in selected patients. The purpose of this study was to determine if selection criteria for combined resection could be identified using major morbidity or mortality as an avoidable outcome.
Methods
We queried the American College of Surgeons National Surgery Quality Improvement Program dataset from 2005 to 2010 for combined liver and colorectal resections for colorectal cancer using procedure and diagnosis codes. These patients were compared to colorectal cancer patients receiving colectomy alone and patients receiving liver-directed surgery for secondary liver cancer.
Results
During the study period, 1,641 (53.1 %) of patients underwent colectomy alone, 1,113 (36 %) underwent liver-directed surgery alone, and 334 (10.9 %) underwent combined colectomy and liver-directed surgery for colorectal cancer. The combined patient population had statistically significant increases in American Society of Anesthesiologists class, preoperative ascites, preoperative systemic inflammatory response syndrome/sepsis, weight loss, functional dependence, and decreased serum albumin compared to the other cohorts. While major hepatectomy was less frequent in the combined cohort, the rate of rectal resection was similar to the colectomy-alone cohort. These selection disparities resulted in a subsequent increase in composite major morbidity, return to operating room, infectious complications, and length of stay in combined patients.
Conclusions
While combined resection in patients with synchronous colorectal cancer hepatic metastases may be feasible, it is associated with considerable increase in morbidity without application of stringent selection criteria. We recommend only patients without known risk factors for perioperative morbidity and infectious complications be considered for this approach.
Similar content being viewed by others
References
Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ (2009) Cancer statistics, 2009. CA Cancer J Clin 59:225–249
Chafai N, Chan CL, Bokey EL, Dent OF, Sinclair G, Chapuis PH (2005) What factors influence survival in patients with unresected synchronous liver metastases after resection of colorectal cancer? Colorectal Dis 7:176–181
Rougier P, Milan C, Lazorhtes F, Fourtanier G, Partensky C, Baumel H, Faivre J (1995) Prospective study of prognostic factors in patients with unresected hepatic metastases from colorectal cancer. Br J Surg 82:1397–1400
Stangl R, Altendorf-Hofmann A, Charnley RM, Scheele J (1994) Factors influencing the natural history of colorectal liver metastases. Lancet 343:1405–1410
Al-asfoor A, Fedorowicz Z, Lodge M (2008) Resection versus no intervention or other surgical interventions for colorectal metastases. Cochrane Database Syst Rev CD006039
Tomlinson J, Jarnagin W, DeMatteo R, Fong Y, Kornprat P, Gonen M, Kemeny N, Brennan MF, Blumgart LH, D’Angelica M (2008) Actual 10-year survival after resection of colorectal liver metastases defines cure. J Clin Oncol 25:4575–4580
Pawlik T, Scoggins C, Zorzi D, Abdalla EK, Andres A, Eng C, Curley SA, Loyer EM, Muratore A, Mentha G, Capussotti L, Cauthey JN (2005) Effect of surgical margin status on survival and recurrence after hepatic resection of colorectal metastases. Ann Surg 241:715–724
Portier G, Elias D, Bouche O, Rougier P, Bosset JF, Saric J, Belghiti J, Piedbois P, Guimbaud R, Nordinger B, Bugat R, Lazorthes F, Bedenne L (2006) Multicenter randomized trial of adjuvant fluorouracil and folinic acid compared with surgery alone after resection of colorectal liver metastases: FFCD ACHBTH AURC 9002 trial. J Clin Oncol 24:4976–4982
Aloia T, Vauthey J, Loyer E, Ribero D, Pawlik TM, Wei SH, Curley SA, Zorzi D, Abdalla EK (2006) Solitary colorectal liver metastasis: resection determined outcome. Arch Surg 141:460–466
Fong Y, Fortner J, Sun R, Brennan M, Blumgart L (1999) Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. Ann Surg 230:309–318
Minagawa M, Makuuchi M, Torzilli G, Takayama T, Kawasaki S, Kosuge T, Yamamoto J, Imamura H (2000) Extension of the frontiers of surgical indications in the treatment of liver metastases from colorectal cancer: long term results. Ann Surg 231:487–499
Bolton J, Fuhrman G (2000) Survival after resection of multiple bilobar hepatic metastases from colorectal carcinoma. Ann Surg 231:743–751
Choti M, Sitzmann J, Tiburi M, Sumetchotimetha W, Rangsin R, Schulick RD, Lillemoe KD, Yeo CJ, Cameron JL (2002) Trends in long term survival following liver resection for hepatic colorectal metastases. Ann Surg 235:759–766
De Santibanes E, Lasalle F, McCormack L, Pekolj J, Quintana GO, Vaccaro C, Benati M (2002) Simultaneous colorectal and hepatic resections for colorectal cancer: postoperative and long term outcomes. J Am Coll Surg 195:196–202
Reddy S, Barbas A, Clary B (2009) Synchronous colorectal liver metastases: is it time to reconsider traditional paradigms of management? Ann Surg Oncol 16:2395–2410
Hillingso J, Willie-Jorgensen P (2008) Staged or simultaneous resection of synchronous liver metastases from colorectal cancer—a systematic review. Colorectal Dis 11:3–10
Brouquet A, Mortenson M, Vauthey J, Rodriguez-Bigas MA, Overman MJ, Chang GJ, Kopetz S, Garrett C, Curley SA, Abdalla EK (2010) Surgical strategies for synchronous colorectal liver metastases in 156 consecutive patients: classic, combined, or reverse strategy? J Am Coll Surg 210:934–941
Minagawa M, Yamamoto J, Miwa S, Sakamoto Y, Kokudo N, Kosuge T, Miyagawa S, Maskuuchi M (2006) Selection criteria for simultaneous resection in patients with synchronous liver metastasis. Arch Surg 141:1006–1012
Reddy S, Pawlik T, Zorzi D, Gleisner AL, Ribero D, Assumpcao L, Barbas AS, Abdalla EK, Choti MA, Vauthey JN, Ludwig KA, Mantyh CR, Morse MA, Clary BM (2007) Simultaneous resections of colorectal cancer and synchronous liver metastases: a multi-institutional analysis. Ann Surg Oncol 14:3481–3491
Thelen A, Jonas S, Benckert C, Spinelli A, Lopez-Hänninen E, Rudolph B, Neumann U, Neuhasus P (2007) Simultaneous versus staged liver resection of synchronous liver metastases from colorectal cancer. Int J Colorectal Dis 22:1269–1276
Jovine E, Biolchini F, Talarico F, Lerro FM, Mastrangelo L, Selleri S, Landolfo G, Martuzzi F, Iusco DR, Lazzari A (2006) Major hepatectomy in patients with synchronous colorectal liver metastases: whether or not a contraindication to simultaneous colorectal and liver resection? Colorectal Dis 9:245–252
Martin R, Paty P, Fong Y et al (2003) Simultaneous liver and colorectal resections are safe for synchronous colorectal liver metastasis. J Am Coll Surg 197:233–242
Martin R, Augenstein V, Reuter N, Scoggins C, McMasters K (2009) Simultaneous versus staged resection for synchronous colorectal cancer liver metastases. J Am Coll Surg 208:842–852
Abbott DE, Cantor SB, Hu CY, Aloia TA, You YN, Nouyen S, Chang GJ (2012) Optimizing clinical and economic outcomes of surgical therapy for patients with colorectal cancer and synchronous liver metastases. J Am Coll Surg 215:262–70
Fink AS, Campbell DA Jr, Mentzer RM Jr, Henderson WG, Daley J, Bannister J, Hur K, Khuri SF (2002) The National Surgical Quality Improvement Program in non-veterans administration hospitals: initial demonstration of feasibility. Ann Surg 236:344–353, discussion 353–354
Worni M, Mantyh C, Akushevich I, Pietrobon R, Clary B (2012) Is there a role for simultaneous hepatic and colorectal resections? A contemporary view from NSQIP. J Gastrointest Surg 16:2074–2085
Author information
Authors and Affiliations
Corresponding author
Appendix
Appendix
Rights and permissions
About this article
Cite this article
McKenzie, S.P., Vargas, H.D., Evers, B.M. et al. Selection criteria for combined resection of synchronous colorectal cancer hepatic metastases: a cautionary note. Int J Colorectal Dis 29, 729–735 (2014). https://doi.org/10.1007/s00384-013-1828-0
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00384-013-1828-0